NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

0.70
Delayed Data
As of May 22
 +0.01 / +1.45%
Today’s Change
0.42
Today|||52-Week Range
1.30
+11.11%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 1.90, with a high estimate of 2.00 and a low estimate of 1.25. The median estimate represents a +171.43% increase from the last price of 0.70.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in NovaBay Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.08
Sales
$510.0K
Reporting Date
May 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 7.41%
 
 
 
 
 
 
Growthannually 23.65%
 
 
 
 
 
 

Sales

Growthquarterly 32.47%
 
 
 
 
 
 
Growthannually 364.91%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account